title: [Utility and limits of nuclear medicine in the follow-up of differentiated thyroid carcinoma].
abstract: Radionuclide therapy using iodine-131 is widely employed in the work-up of differentiated thyroid carcinoma. After a brief introduction on physical and dosimetry characteristics of radioactive iodine, this paper suggests state of the arts protocol for the ablation of thyroid remnants and for the treatment of metastatic disease. Diagnostic applications of Nuclear Medicine in these tumors are critically evaluated as well, from the use of iodine-131 whole-body scan to 18F-FDG PET and other new diagnostic tools. Finally, a brief description of new radionuclide treatments is reported
authors.affiliation: U.O. Medicina Nucleare Istituto Clinico Humanitas, Rozzano, Milano. arturo.chiti@humanitas.it
authors.forename: Arturo
authors.initials: A
authors.lastname: Chiti
authors.forename: Eva
authors.initials: E
authors.lastname: Orunesu
authors.forename: Marcello
authors.initials: M
authors.lastname: Rodari
mesh_terms: D002277:Carcinoma / Q000000981:diagnostic imaging* / Q000532:radiotherapy / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D007457:Iodine Radioisotopes; D011877:Radionuclide Imaging; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy / Q000601:surgery
chemical_list: D007457:Iodine Radioisotopes